David, Robert <br/><br/>
Stem Cell Research on Cardiology 

 - Basel, Switzerland  MDPI - Multidisciplinary Digital Publishing Institute  2020 
 - 1 electronic resource (356 p.) 
<br/><br/> Open Access 
<br/><br/> Even today, cardiovascular diseases are the main cause of death worldwide, and therapeutic approaches are very restricted. Due to the limited regenerative capabilities of terminally differentiated cardiomyocytes post injury, new strategies to treat cardiac patients are urgently needed. Post myocardial injury, resident fibroblasts begin to generate the extracellular matrix, resulting in fibrosis, and finally, cardiac failure. Recently, preclinical investigations and clinical trials raised hope in stem cell-based approaches, to be an effective therapy option for these diseases. So far, several types of stem cells have been identified to be promising candidates to be applied for treatment: cardiac progenitor cells, bone marrow derived stem cells, embryonic and induced pluripotent stem cells, as well as their descendants. Furthermore, the innovative techniques of direct cardiac reprogramming of cells offered promising options for cardiovascular research, in vitro and in vivo. Hereby, the investigation of underlying and associated mechanisms triggering the therapeutic effects of stem cell application is of particular importance to improve approaches for heart patients. This Special Issue of Cells provides the latest update in the rapidly developing field of regenerative medicine in cardiology. 
<br/><br/><br/>Creative Commons 
<br/><br/><br/>English 
<br/><br/><label>ISBN: </label>books978-3-03943-193-9 9783039431922 9783039431939 
<br/><br/><label>Standard No.: </label>10.3390/books978-3-03943-193-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Research & information: general<br/>Biology, life sciences
<br/><br/><label>Subjects--Index Terms: </label>Fabry disease human embryonic stem cells CRISPR/Cas9 genomic editing Mass spectrometry proteomic analysis hypertrophic cardiomyopathy disease model physical exercise cardiac cellular regeneration microRNA (miR) Akt signaling cardiomyocyte proliferation cardiac hypertrophy cardioprotection myocarditis inflammation leukocytes cardiomyocytes multi-electrode-array micro-electrode-array MEA drug/toxicity screening field potential arrhythmia electrocardiography cardiac regeneration stem cells iPSC PSC ESC cardiovascular disease regeneration cardiac progenitor cells induced pluripotent stem cells transdifferentiation direct reprogramming genetic engineering cardiac tissue engineering biomaterials 18F-FDG PET cardiac induced cells cardiac function non-invasive imaging human pluripotent stem cell ventricular maturation bone marrow stem cells angiogenesis myocardial infarction human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) iPS cells big conductance calcium activated potassium channel (BK) Maxi-K slo1 KCa1.1 iberiotoxin long QT syndrome mesenchymal stromal cells (MSC) mRNA miRNA cardiac reprogramming cardiac differentiation cardiovascular diseases adult stem cells myocardial infraction 3D printing 3D model bioprinting cardiovascular medicine heart myocardium heart valves vascular graft endothelialization tissue engineering decorin fibronectin electrospinning endothelial progenitor cells bioreactor biostable polyurethane MicroRNA Mir-133 coronary heart disease biomarker meta-analysis